To Top

Search By Topic

Innovation

191 Articles available
Drug Development

Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties

PAO-M12-17-NI-025
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
CRISPR

Charles River Expands CRISPR Offerings with Second License

PAO-M12-17-NI-022
Innovation

Molex Expands Strategic Investment Platform with Venture Initiative

PR-M12-17-NI-011
Innovation

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

PR-M12-17-NI-007
Oncology

Phase III Study Confirms AbbVie Leukemia Combo Meets Endpoint

PAO-M12-17-NI-021
Drug Development

New Generic for Kenalog-40 Approved

PAO-M12-17-NI-020
3D Printing

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

PAO-M12-17-NI-018
Hemophilia

Results of New Gene Therapy Revealed at Hemophilia Meeting

PAO-M12-17-NI-017
Drug Development

ZUMA-1 Study of Yescarta Reports 58% Complete Remission

PAO-M12-17-NI-016
Immunotherapy

Phase II Results Reveal High-Performance Immunotherapy

PAO-M12-17-NI-015
Innovation

Bioinformatics Solutions, Inc. Chooses Science Exchange as the Primary Online Channel to Offer Protein de novo Sequencing Services to Scientists

PR-M12-17-NI-005
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010
Innovation

University of Michigan Innovates with Kevlar Cartilage

PAO-M12-17-NI-009
Drug Development

U.S. Patient Receives Kite’s Yescarta CART-T Therapy

PAO-M12-17-NI-008
Medical Application

FDA Clears KardiaBand Apple Watch Heart Monitoring App

PAO-M12-17-NI-006
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

PAO-M12-17-NI-004
Drug Development

Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma

PAO-M12-17-NI-003
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

PAO-M12-17-NI-002
Innovation

New Ferring and Aché Laboratórios Farmacêuticos Facility Opens to Optimise Drug Delivery Using Nanotechnology

PR-M11-17-NI-018
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Research

Study Finds Less Teflon in Environment Leads to Less Brain Damage

PAO-M11-17-NI-052
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
FDA Approval

Advanced Follicular Lymphoma Treatment Approved

PAO-M11-17-NI-048
Expansion

Fresenius Kabi Plans $100 Million North Carolina Expansion

PAO-M11-17-NI-047
Gene Editing

Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems

PAO-M11-17-NI-046
//Fix for text overflow in cards